39 results on '"Xing, Charles"'
Search Results
2. 1343 Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors
3. 1342 A novel dual CAB Nectin-4 x CD3 bispecific antibody targeting solid tumors
4. Abstract 1879: A novel dual CAB nectin-4 x CD3 bispecific antibody targeting solid tumors
5. Abstract 1541: NextGen conditionally active biologic (CAB) anti-Nectin-4-ADC with improved stability and safety
6. Abstract 1871: Novel conditionally active bispecific HER2 x CD3 T cell engager targeting solid tumors
7. Topical Potassium Channel Blockage Improves Pharyngeal Collapsibility
8. BAY 2253651 for the treatment of obstructive sleep apnoea: a multicentre, double-blind, randomised controlled trial (SANDMAN)
9. Abstract 694: Novel conditionally active bispecific EpCAM x CD3 T cell engagers targeting solid tumors
10. Abstract 1870: Novel conditionally active bispecific T cell engagers targeting solid tumors
11. Generating tumor-selective conditionally active biologic anti-CTLA4 antibodies via protein-associated chemical switches
12. Abstract 4560: Conditionally active biologics (CAB): A novel class of molecules targeting solid tumors
13. Abstract 5698: Novel conditionally active bispecific T cell engagers targeting solid tumors
14. Studies of Wafer Backside Micro-arcing Prevention In Encore Ta Process
15. Study on Effects of Slurry Key Factors on Advanced Oxide CMP Performance
16. Novel Approach for W Loss Defect Prevention on WCMP Re-Clean Process
17. The Influence of The SIN Cap Process on The Voltage Breakdown and Electromigration Performance of Dual Damascene Cu Interconnects
18. Study on the Ring Type Crater Defect Reduction in Cu CMP Process
19. A Robust Shallow Trench Isolation High Density Plasma Chemical Vapor Deposition Void Free Process for 0.13μm CMOS Technology
20. Fab Environment Effect on Crescent Pits Defect in Cu Metallization Process
21. Effective Approach for Hillock Defect Reduction in Cu Metallization Process
22. Study on Al-Ge Bonding and Quality Improvement in CMEMS Process
23. Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo
24. Abstract 356: Novel conditionally active biologic (CAB) antibody targeting EpCAM demonstrates anti-tumor efficacy in vivo
25. Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies
26. Abstract 2708: Potent CAB CTLA4 antibody to reduce immune side effects and toxicities associated with single-agent and combination cancer immuno therapies
27. Abstract 4555: Potent Conditionally Active Biologic (CAB) PD-1 antibodies to reduce systemic toxicities associated with single agent and combination therapies
28. Abstract 833: Anti-tumor efficacy of BA3021, a novel Conditionally Active Biologic (CAB) anti-ROR2 ADC
29. Abstract 827: Anti-tumor efficacy of BA3011, a novel Conditionally Active Biologic (CAB) anti-AXL-ADC
30. Kinetics of 5-HT2BReceptor Signaling: Profound Agonist-Dependent Effects on Signaling Onset and Duration
31. Fused tricyclic indoles as S1P1 agonists with robust efficacy in animal models of autoimmune disease
32. A Novel 1T-1D DRAM Cell for Embedded Application
33. Discovery and characterization of potent and selective 4-oxo-4-(5-(5-phenyl-1,2,4-oxadiazol-3-yl)indolin-1-yl)butanoic acids as S1P1 agonists
34. Discovery of fused bicyclic agonists of the orphan G-protein coupled receptor GPR119 with in vivo activity in rodent models of glucose control
35. WCVD Seam Hole Improvement to Prevent BEOL Copper Diffusion
36. Investigation of Mechanical Effects on Advanced Copper CMP
37. Mechanism and Solution of Isb Failure on Deep Trench DRAM
38. N-Oleoyldopamine Enhances Glucose Homeostasis through the Activation of GPR119
39. Discovery of the First Potent and Orally Efficacious Agonist of the Orphan G-Protein Coupled Receptor 119
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.